Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).

Florent, C

Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). [electronic resource] - European journal of gastroenterology & hepatology Mar 1996 - 229-33 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0954-691X

10.1097/00042737-199603000-00008 doi


Administration, Oral
Adolescent
Adult
Aged
Aminosalicylic Acids--administration & dosage
Anastomosis, Surgical
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Chemoprevention
Colonic Diseases--pathology
Colonoscopy
Constriction, Pathologic--pathology
Crohn Disease--pathology
Double-Blind Method
Drug Tolerance
Female
Humans
Ileal Diseases--pathology
Male
Mesalamine
Middle Aged
Placebos
Recurrence
Ulcer--pathology